Literature DB >> 29844813

Metastatic lymph node ratio and Lauren classification are independent prognostic markers for survival rates of patients with gastric cancer.

Huan Wang1,2, Xiao-Ming Xing3, Lei-Na Ma1, Lian Liu4, Jing Hao4, Ling-Xin Feng1, Zhuang Yu1.   

Abstract

The long-term prognosis for patients with gastric cancer (GC) following radical resection remains poor. It is important to identify prognostic markers to predict survival. In the present retrospective study, the association between the metastatic lymph node ratio (rN) and the Lauren classification on predicting overall survival (OS) was investigated. Furthermore, a subgroup analysis was performed on the Lauren classification, using rN score as an independent prognostic marker. In total, 261 pathologically confirmed patients with GC were retrospectively reviewed. Kaplan-Meier curves and Cox's proportional hazards modeling were applied to analyze the OS of patients, and were utilized in the subgroup analysis. Receiver operating characteristic (ROC) curves were used to compare the accuracy of prognosis between the rN score and lymph node staging (N stage). The χ2 test was used to analyze the association between the rN score and Lauren classification. Univariate survival and multivariate analysis demonstrated that the rN score and Lauren classification were significant prognostic markers for patients with GC. The ROC analysis confirmed that the rN score was more effective than N staging for OS prediction. Subgroup analysis indicated that rN was more accurate at predicting OS time in patients with diffuse type GC. The rN score and the Lauren classification were independent prognostic factors for the OS of patients with GC following radical resection, and the rN score was more accurate than the N stage for predicting the prognosis. Overall, the rN may be suitable as an independent predictor for OS in patients with diffuse type GC.

Entities:  

Keywords:  Lauren classification; gastric cancer; lymph node staging; metastatic lymph node ratio; prognosis

Year:  2018        PMID: 29844813      PMCID: PMC5958805          DOI: 10.3892/ol.2018.8497

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  39 in total

1.  Evaluation of the prognostic value of the metastatic lymph node ratio for gastric cancer.

Authors:  Bao-Yan Zhang; Jing Yuan; Zhen-Shuang Cui; Zhong-Wu Li; Xiang-Hong Li; You-Yong Lu
Journal:  Am J Surg       Date:  2013-10-12       Impact factor: 2.565

2.  Prognostic impact of lymph node retrieval and ratio in gastric cancer: a U.S. single center experience.

Authors:  Joyce Wong; Shams Rahman; Nadia Saeed; Hui-Yi Lin; Khaldoun Almhanna; Ravi Shridhar; Sarah Hoffe; Kenneth L Meredith
Journal:  J Gastrointest Surg       Date:  2013-10-16       Impact factor: 3.452

3.  Superiority of the ratio between negative and positive lymph nodes for predicting the prognosis for patients with gastric cancer.

Authors:  Jingyu Deng; Rupeng Zhang; Liangliang Wu; Li Zhang; Xuejun Wang; Yong Liu; Xishan Hao; Han Liang
Journal:  Ann Surg Oncol       Date:  2014-10-16       Impact factor: 5.344

4.  Prognostic significance of the metastatic lymph node ratio in patients with gastric cancer.

Authors:  Sung Ryol Lee; Hyung Ook Kim; Byung Ho Son; Jun Ho Shin; Chang Hak Yoo
Journal:  World J Surg       Date:  2012-05       Impact factor: 3.352

5.  Comparison of metastatic lymph node ratio staging system with the 7th AJCC system for colorectal cancer.

Authors:  Jizhun Zhang; Liang Lv; Yingjiang Ye; Kewei Jiang; Zhanlong Shen; Shan Wang
Journal:  J Cancer Res Clin Oncol       Date:  2013-09-22       Impact factor: 4.553

6.  Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer.

Authors:  X-J Wu; R-L Miao; Z-Y Li; Z-D Bu; L-H Zhang; A-W Wu; X-L Zong; S-X Li; F Shan; X Ji; H Ren; J-F Ji
Journal:  Eur J Surg Oncol       Date:  2015-04-03       Impact factor: 4.424

7.  Value of Positive Lymph Node Ratio for Predicting Postoperative Distant Metastasis and Prognosis in Esophageal Squamous Cell Carcinoma.

Authors:  Jia Huang; Wenhao Hu; Linrong Pang; Jun Chen; Hui Yang
Journal:  Oncol Res Treat       Date:  2015-08-18       Impact factor: 2.825

Review 8.  Pathohistological classification systems in gastric cancer: diagnostic relevance and prognostic value.

Authors:  Felix Berlth; Elfriede Bollschweiler; Uta Drebber; Arnulf H Hoelscher; Stefan Moenig
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

9.  Lymph node ratio is an independent prognostic factor for patients after resection of pancreatic cancer.

Authors:  Han-xiang Zhan; Jian-wei Xu; Lei Wang; Guang-yong Zhang; San-yuan Hu
Journal:  World J Surg Oncol       Date:  2015-03-13       Impact factor: 2.754

10.  Clinical Relevance of the Tumor Location-Modified Lauren Classification System of Gastric Cancer.

Authors:  Jang Kyu Choi; Young Suk Park; Do Hyun Jung; Sang Yong Son; Sang Hoon Ahn; Do Joong Park; Hyung Ho Kim
Journal:  J Gastric Cancer       Date:  2015-09-30       Impact factor: 3.720

View more
  6 in total

1.  Prognostic significance of serum alkaline phosphatase and lactate dehydrogenase levels in patients with unresectable advanced gastric cancer.

Authors:  Tsutomu Namikawa; Nobuko Ishida; Sachi Tsuda; Kazune Fujisawa; Eri Munekage; Jun Iwabu; Masaya Munekage; Sunao Uemura; Shigehiro Tsujii; Takahiko Tamura; Tomoaki Yatabe; Hiromichi Maeda; Hiroyuki Kitagawa; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  Gastric Cancer       Date:  2018-11-11       Impact factor: 7.370

2.  Neutrophil-to-lymphocyte ratio and C-reactive protein-to-albumin ratio as prognostic factors for unresectable advanced or recurrent gastric cancer.

Authors:  Tsutomu Namikawa; Shigeto Shimizu; Keiichiro Yokota; Nobuhisa Tanioka; Masaya Munekage; Sunao Uemura; Hiromichi Maeda; Hiroyuki Kitagawa; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  Langenbecks Arch Surg       Date:  2021-10-15       Impact factor: 3.445

3.  Clinicopathological differences, risk factors and prognostic scores for western patients with intestinal and diffuse-type gastric cancer.

Authors:  Cristina Díaz Del Arco; Lourdes Estrada Muñoz; Luis Ortega Medina; Elena Molina Roldán; M Ángeles Cerón Nieto; Soledad García Gómez de Las Heras; M Jesús Fernández Aceñero
Journal:  World J Gastrointest Oncol       Date:  2022-06-15

4.  The Role of the Lymph Node Ratio in Advanced Gastric Cancer After Neoadjuvant Chemotherapy.

Authors:  Karol Rawicz-Pruszyński; Bogumiła Ciseł; Radosław Mlak; Jerzy Mielko; Magdalena Skórzewska; Magdalena Kwietniewska; Agnieszka Pikuła; Katarzyna Gęca; Katarzyna Sędłak; Andrzej Kurylcio; Wojciech P Polkowski
Journal:  Cancers (Basel)       Date:  2019-12-01       Impact factor: 6.639

5.  HER2 protein expression correlates with Lauren classification and P53 in gastric cancer patients.

Authors:  Yiming Chu; Hongbo Li; Dan Wu; Qingqu Guo
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

Review 6.  Is there still a place for conventional histopathology in the age of molecular medicine? Laurén classification, inflammatory infiltration and other current topics in gastric cancer diagnosis and prognosis.

Authors:  Cristina Díaz Del Arco; Luis Ortega Medina; Lourdes Estrada Muñoz; Soledad García Gómez de Las Heras; Mª Jesús Fernández Aceñero
Journal:  Histol Histopathol       Date:  2021-02-10       Impact factor: 2.303

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.